Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Bocholt – page 24

364 clinical trials in Bocholt, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Bocholt at a glance
364
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

364 trials in Bocholt

Open in trial search

Breast cancer female

Not recruiting

Study of Atezolizumab, Pertuzumab, and Trastuzumab for Patients with HER2 Positive Early High-Risk and Locally Advanced Breast Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Fondazione Michelangelo

Study Comparing Ceralasertib and Durvalumab with Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer After Previous Treatments

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ceralasertib
  • Sponsor:AstraZeneca AB

Study on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Domvanalimab
  • Sponsor:AstraZeneca AB

Study on Dapagliflozin for Patients with Severe Chronic Kidney Disease to Improve Kidney and Heart Health Outcomes

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Universitair Medisch Centrum Groningen

Study of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Glaxosmithkline Research & Development Limited

Study on Durvalumab and Platinum-Based Drug Combination for Patients with Stage IIB-IIIB Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anhydrous Docetaxel
  • Sponsor:AstraZeneca AB

Bronchitis

Not recruiting

Study on the Effectiveness of Thyme Herb Extract, Primrose Root Tincture, and Ivy Leaf Extract for Patients with Acute Bronchitis

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Dry Extract Of Hederae Folium (5-7.5:1), Extraction Solvent: Ethanol 30% (M/M)
  • Sponsor:Engelhard Arzneimittel GmbH & Co. KG

Study Comparing Standard Chemotherapy with CPX-351 for Adults with Newly Diagnosed Acute Myeloid Leukemia (AML) and Intermediate or Adverse Genetics

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Universitaetsklinikum Ulm AöR

Study on Elinzanetant for Treating Hot Flashes in Women with or at High Risk for Hormone-Receptor Positive Breast Cancer

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Elinzanetant
  • Sponsor:Bayer Consumer Care AG

Study on the Effectiveness of Autogene Cevumeran in Patients with ctDNA Positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Autogene Cevumeran
  • Sponsor:BioNTech SE

Cardiac failure

Not recruiting

Study of XXB750 and Drug Combination for Patients with Heart Failure

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azilsartan Medoxomil
  • Sponsor:Novartis Pharma AG

Study on Atezolizumab and Trastuzumab Emtansine for Patients with HER2-Positive Breast Cancer at High Risk of Recurrence After Preoperative Therapy

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:F. Hoffmann-La Roche AG

Other cities in Germany

The busiest research cities in the country

All 505 cities in Germany

Clinical research in Bocholt

What the registry says about research in the country

01 Neuropathic Pain Research

Investigating novel treatments for patients with diabetic polyneuropathy, focusing on therapeutic interventions to manage chronic pain symptoms. These trials aim to evaluate the effectiveness of add-on treatments for improving patient quality of life.

  • Diabetic Neuropathy Management
  • Pain Control Optimization
  • Treatment Tolerability Assessment

Current studies are exploring innovative approaches to chronic pain management in diabetes patients.

02 Trauma-Related Neuropathy

Clinical research focusing on post-operative and traumatic peripheral neuropathy. These studies evaluate new therapeutic options for patients experiencing chronic pain following surgery or injury.

  • Post-Surgical Pain Management
  • Trauma-Induced Neuropathy
  • Therapeutic Efficacy Studies

Researchers are working to develop more effective pain management solutions for trauma patients.

03 Central Neuropathy Studies

Comprehensive research into central neuropathy of various origins, investigating new treatment approaches for chronic pain management. These trials assess both efficacy and patient tolerance to innovative therapies.

  • Central Pain Syndromes
  • Multi-Origin Neuropathy
  • Treatment Response Analysis

The studies aim to advance our understanding of central nervous system pain conditions.

04 Chronic Back Pain Research

Dedicated studies examining new treatment options for patients with chronic back pain. The research focuses on evaluating supplementary therapies to enhance current pain management approaches.

  • Back Pain Management
  • Treatment Combinations
  • Long-term Pain Control

These trials seek to improve the quality of life for individuals suffering from persistent back pain.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.